Skip to content

HUMA

Humacyte, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.43
−2.38%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
8.77x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
3.82x
Price / sales
56.32x
Price / cash flow
-1.23x

Enterprise value

Enterprise value
$105.7M
EV / sales
49.85x
EV / EBITDA
-1.33x
EV / EBIT
-0.95x
Market cap
$119.5M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026